UB-612
V-122
Phase 2 mab completed
Quick answer
UB-612 for COVID-19 is a Phase 2 program (mab) at United Therapeutics Europe Ltd with 4 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- mab
- Status
- completed